NeurologyLive Friday 5 — October 1, 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 1, 2021.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Spasticity and Mobility in MS

In the second session of the "Managing Multiple Sclerosis: A Team Approach," put on in collaboration with the Consortium of MS Centers and International Organization of MS Rehabilitation Therapists, Patty Bobryk, PT, and Lacey Bromley, PT, PhD, discuss spasticity and weakness in multiple sclerosis as well as mobility, mobility aids, and seating.

2: NeurologyLive Top Expert Interviews: September 2021

Expert clinicians offer their perspectives on the ongoing shortage of neurologists, transgender and gender-diverse individuals with migraine, artificial intelligence and neuroimaging, Student Sleep Health Week 2021, and the importance of rehabilitation therapy in multiple sclerosis.

3: NeuroVoices: David R. Lynch, MD, PhD, on the First Potentially Approved Friedreich Ataxia Treatment

The professor of neurology at the University of Pennsylvania Perelman School of Medicine discussed the state of care for Friedrich ataxia and omaveloxolone’s potential to become its first approved therapy, as well as the findings from the MOXIe trial an dwhy the mechanistic action of omaveloxolone makes it so effective to treat these patients.

4: Treating Millennial Patients With Multiple Sclerosis

Mitzi Joi Williams, MD, board-certified neurologist and multiple sclerosis specialist, and founder and CEO, Joi Life Wellness Group Multiple Sclerosis Center, shares her insights about differences in treatment and approach between millennial patients and the older generations of those with MS.

5: Peer Exchange: Identifying and Managing NMOSD

In Episode 4 of the NeurologyLive Peer Exchange series, "Managing Neuromyelitis Optica Spectrum Disorders (NMOSD)," Brian G. Weinshenker, MD, detailed the types of testing that can help neurologists distinguish between acute attacks of NMOSD and multiple sclerosis, as well as therapies that can be used to help manage patients with NMOSD.

—————————————————
Introducing: Giants of Multiple Sclerosis™

Recognize and celebrate the individuals who have achieved landmark successes within multiple sclerosis! Giants of Multiple Sclerosis™ is a premier neuroscience award that celebrates pioneers, innovators, and future generations of leaders who have been selected by their peers for their remarkable achievements in Multiple Sclerosis.

More information will be announced at a welcome reception during the 2021 Consortium of MS Centers Annual Meeting.

Click here to RSVP to Attend

Aren't registered for the 2021 CMSC Annual Meeting? Register now.